ICAD.PA

Icade Logo

Icade

ICAD.PA

(2.2)
Stock Price

23,14 EUR

-8.83% ROA

-20.23% ROE

-1.98x PER

Market Cap.

1.888.398.102,00 EUR

107.07% DER

19.42% Yield

-60.86% NPM

Icade Stock Analysis

Icade Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Icade Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.38x), the stock offers substantial upside potential at a bargain price.

2 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

3 ROE

ROE in an average range (3.34%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (1.22%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

6 Dividend Growth

The company's dividend growth has exhibited a remarkable upward trend over the past three years, consistently delivering higher payouts to shareholders.

7 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (858), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

8 DER

The stock is burdened with a heavy load of debt (122%), making it financially unstable and potentially risky for investors.

9 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

11 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

Icade Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Icade Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Icade Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Icade Revenue
Year Revenue Growth
2004 994.400.000
2005 1.179.200.000 15.67%
2006 1.327.200.000 11.15%
2007 1.498.900.000 11.46%
2008 1.615.200.000 7.2%
2009 1.505.600.000 -7.28%
2010 1.431.800.000 -5.15%
2011 1.492.000.000 4.03%
2012 1.499.300.000 0.49%
2013 1.456.700.000 -2.92%
2014 1.724.700.000 15.54%
2015 1.431.300.000 -20.5%
2016 1.487.200.000 3.76%
2017 1.629.100.000 8.71%
2018 1.772.600.000 8.1%
2019 1.527.200.000 -16.07%
2020 1.446.700.000 -5.56%
2021 1.792.100.000 19.27%
2022 1.961.400.000 8.63%
2023 1.656.900.000 -18.38%
2024 2.787.200.000 40.55%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Icade Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 -1 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Icade General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 210.200.000
2005 236.000.000 10.93%
2006 246.200.000 4.14%
2007 0 0%
2008 0 0%
2009 935.200.000 100%
2010 903.600.000 -3.5%
2011 24.600.000 -3573.17%
2012 111.100.000 77.86%
2013 85.800.000 -29.49%
2014 114.500.000 25.07%
2015 97.300.000 -17.68%
2016 88.200.000 -10.32%
2017 101.200.000 12.85%
2018 94.200.000 -7.43%
2019 83.900.000 -12.28%
2020 92.000.000 8.8%
2021 107.900.000 14.74%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Icade EBITDA
Year EBITDA Growth
2004 225.900.000
2005 266.900.000 15.36%
2006 404.500.000 34.02%
2007 290.500.000 -39.24%
2008 611.600.000 52.5%
2009 893.400.000 31.54%
2010 1.453.300.000 38.53%
2011 473.700.000 -206.8%
2012 501.700.000 5.58%
2013 573.600.000 12.53%
2014 525.900.000 -9.07%
2015 821.800.000 36.01%
2016 515.400.000 -59.45%
2017 594.300.000 13.28%
2018 631.400.000 5.88%
2019 586.100.000 -7.73%
2020 567.100.000 -3.35%
2021 621.200.000 8.71%
2022 645.700.000 3.79%
2023 280.400.000 -130.28%
2024 260.000.000 -7.85%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Icade Gross Profit
Year Gross Profit Growth
2004 615.400.000
2005 696.000.000 11.58%
2006 774.700.000 10.16%
2007 290.900.000 -166.31%
2008 -652.500.000 144.58%
2009 570.400.000 214.39%
2010 710.900.000 19.76%
2011 698.300.000 -1.8%
2012 688.900.000 -1.36%
2013 689.900.000 0.14%
2014 768.400.000 10.22%
2015 713.800.000 -7.65%
2016 741.600.000 3.75%
2017 782.500.000 5.23%
2018 849.500.000 7.89%
2019 402.100.000 -111.27%
2020 720.300.000 44.18%
2021 780.000.000 7.65%
2022 818.600.000 4.72%
2023 464.700.000 -76.16%
2024 1.042.400.000 55.42%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Icade Net Profit
Year Net Profit Growth
2004 60.300.000
2005 70.800.000 14.83%
2006 225.500.000 68.6%
2007 36.900.000 -511.11%
2008 312.500.000 88.19%
2009 527.100.000 40.71%
2010 1.218.000.000 56.72%
2011 93.000.000 -1209.68%
2012 51.500.000 -80.58%
2013 126.900.000 59.42%
2014 151.500.000 16.24%
2015 -187.100.000 180.97%
2016 44.700.000 518.57%
2017 165.500.000 72.99%
2018 154.900.000 -6.84%
2019 300.200.000 48.4%
2020 79.500.000 -277.61%
2021 400.100.000 80.13%
2022 54.100.000 -639.56%
2023 -1.122.400.000 104.82%
2024 -720.000.000 -55.89%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Icade Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 3
2005 2 0%
2006 2 0%
2007 1 0%
2008 6 100%
2009 11 40%
2010 24 56.52%
2011 2 -2200%
2012 1 0%
2013 2 50%
2014 2 0%
2015 -3 200%
2016 1 0%
2017 2 100%
2018 2 0%
2019 4 50%
2020 1 -300%
2021 5 80%
2022 1 0%
2023 -15 100%
2024 -10 -55.56%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Icade Free Cashflow
Year Free Cashflow Growth
2004 -18.000.000
2005 -83.200.000 78.37%
2006 -51.400.000 -61.87%
2007 -494.500.000 89.61%
2008 -862.400.000 42.66%
2009 -188.300.000 -357.99%
2010 -383.300.000 50.87%
2011 -505.100.000 24.11%
2012 -347.100.000 -45.52%
2013 -182.000.000 -90.71%
2014 -198.900.000 8.5%
2015 -328.000.000 39.36%
2016 -614.700.000 46.64%
2017 -340.500.000 -80.53%
2018 -169.100.000 -101.36%
2019 -416.900.000 59.44%
2020 119.500.000 448.87%
2021 -497.600.000 124.02%
2022 -234.200.000 -112.47%
2023 18.300.000 1379.78%
2024 9.600.000 -90.63%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Icade Operating Cashflow
Year Operating Cashflow Growth
2004 127.700.000
2005 65.500.000 -94.96%
2006 120.000.000 45.42%
2007 152.400.000 21.26%
2008 -84.500.000 280.36%
2009 197.400.000 142.81%
2010 61.800.000 -219.42%
2011 221.100.000 72.05%
2012 78.500.000 -181.66%
2013 170.100.000 53.85%
2014 486.200.000 65.01%
2015 305.300.000 -59.25%
2016 215.000.000 -42%
2017 337.400.000 36.28%
2018 356.300.000 5.3%
2019 369.000.000 3.44%
2020 650.100.000 43.24%
2021 529.100.000 -22.87%
2022 312.900.000 -69.1%
2023 322.900.000 3.1%
2024 105.100.000 -207.23%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Icade Capital Expenditure
Year Capital Expenditure Growth
2004 145.700.000
2005 148.700.000 2.02%
2006 171.400.000 13.24%
2007 646.900.000 73.5%
2008 777.900.000 16.84%
2009 385.700.000 -101.69%
2010 445.100.000 13.35%
2011 726.200.000 38.71%
2012 425.600.000 -70.63%
2013 352.100.000 -20.87%
2014 685.100.000 48.61%
2015 633.300.000 -8.18%
2016 829.700.000 23.67%
2017 677.900.000 -22.39%
2018 525.400.000 -29.03%
2019 785.900.000 33.15%
2020 530.600.000 -48.12%
2021 1.026.700.000 48.32%
2022 547.100.000 -87.66%
2023 304.600.000 -79.61%
2024 95.500.000 -218.95%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Icade Equity
Year Equity Growth
2004 1.227.900.000
2005 1.161.100.000 -5.75%
2006 1.786.200.000 35%
2007 1.428.000.000 -25.08%
2008 1.479.000.000 3.45%
2009 1.820.400.000 18.75%
2010 2.834.000.000 35.77%
2011 2.740.000.000 -3.43%
2012 2.963.600.000 7.54%
2013 4.579.900.000 35.29%
2014 4.530.199.999 -1.1%
2015 4.267.500.000 -6.16%
2016 4.100.400.000 -4.08%
2017 4.127.300.000 0.65%
2018 3.936.700.000 -4.84%
2019 4.094.800.000 3.86%
2020 8.156.400.000 49.8%
2021 8.639.300.000 5.59%
2022 8.684.500.000 0.52%
2023 5.067.700.000 -71.37%
2023 7.811.700.000 35.13%
2024 4.501.100.000 -73.55%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Icade Assets
Year Assets Growth
2004 3.284.900.000
2005 3.452.000.000 4.84%
2006 4.494.300.000 23.19%
2007 5.374.400.000 16.38%
2008 6.158.700.000 12.73%
2009 5.995.500.000 -2.72%
2010 7.141.900.000 16.05%
2011 7.279.800.000 1.89%
2012 7.802.900.000 6.7%
2013 10.278.800.000 24.09%
2014 10.200.100.000 -0.77%
2015 10.203.700.000 0.04%
2016 10.037.000.000 -1.66%
2017 11.309.000.000 11.25%
2018 11.759.200.000 3.83%
2019 12.513.500.000 6.03%
2020 17.205.000.000 27.27%
2021 17.608.900.000 2.29%
2022 18.218.200.000 3.34%
2023 11.601.000.000 -57.04%
2023 17.530.900.000 33.83%
2024 10.823.500.000 -61.97%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Icade Liabilities
Year Liabilities Growth
2004 2.057.000.000
2005 2.290.900.000 10.21%
2006 2.708.100.000 15.41%
2007 3.946.400.000 31.38%
2008 4.679.700.000 15.67%
2009 4.175.100.000 -12.09%
2010 4.307.900.000 3.08%
2011 4.539.800.000 5.11%
2012 4.839.300.000 6.19%
2013 5.698.900.000 15.08%
2014 5.669.900.000 -0.51%
2015 5.936.200.000 4.49%
2016 5.936.600.000 0.01%
2017 7.181.700.000 17.34%
2018 7.822.500.000 8.19%
2019 8.418.700.000 7.08%
2020 9.048.600.000 6.96%
2021 8.969.600.000 -0.88%
2022 9.533.700.000 5.92%
2023 6.533.300.000 -45.92%
2023 9.719.200.000 32.78%
2024 6.322.400.000 -53.73%

Icade Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
20.68
Net Income per Share
-12.58
Price to Earning Ratio
-1.98x
Price To Sales Ratio
1.21x
POCF Ratio
6.74
PFCF Ratio
42.53
Price to Book Ratio
0.43
EV to Sales
3.5
EV Over EBITDA
28.79
EV to Operating CashFlow
19.61
EV to FreeCashFlow
123.67
Earnings Yield
-0.5
FreeCashFlow Yield
0.02
Market Cap
1,89 Bil.
Enterprise Value
5,49 Bil.
Graham Number
128.81
Graham NetNet
-59.82

Income Statement Metrics

Net Income per Share
-12.58
Income Quality
-0.29
ROE
-0.2
Return On Assets
-0.09
Return On Capital Employed
0.02
Net Income per EBT
0.89
EBT Per Ebit
-6.45
Ebit per Revenue
0.11
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.32
Operating Profit Margin
0.11
Pretax Profit Margin
-0.69
Net Profit Margin
-0.61

Dividends

Dividend Yield
0.19
Dividend Yield %
19.42
Payout Ratio
-0.37
Dividend Per Share
4.84

Operating Metrics

Operating Cashflow per Share
3.7
Free CashFlow per Share
0.59
Capex to Operating CashFlow
0.84
Capex to Revenue
0.15
Capex to Depreciation
9.9
Return on Invested Capital
0.02
Return on Tangible Assets
-0.09
Days Sales Outstanding
90.05
Days Payables Outstanding
233.22
Days of Inventory on Hand
239.74
Receivables Turnover
4.05
Payables Turnover
1.57
Inventory Turnover
1.52
Capex per Share
3.11

Balance Sheet

Cash per Share
15,21
Book Value per Share
59,41
Tangible Book Value per Share
59
Shareholders Equity per Share
58.6
Interest Debt per Share
63.5
Debt to Equity
1.07
Debt to Assets
0.44
Net Debt to EBITDA
18.89
Current Ratio
2.04
Tangible Asset Value
4,47 Bil.
Net Current Asset Value
-2,25 Bil.
Invested Capital
8570400000
Working Capital
2,07 Bil.
Intangibles to Total Assets
0
Average Receivables
0,49 Bil.
Average Payables
0,68 Bil.
Average Inventory
730950000
Debt to Market Cap
2.52

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Icade Dividends
Year Dividends Growth
2000 7
2001 7 14.29%
2002 8 0%
2003 8 0%
2004 10 22.22%
2005 13 30.77%
2006 1 0%
2007 1 0%
2008 2 100%
2009 3 33.33%
2010 7 57.14%
2011 3 -133.33%
2012 4 0%
2013 4 0%
2014 4 0%
2015 4 0%
2016 4 0%
2017 4 25%
2018 4 0%
2019 5 0%
2020 4 0%
2021 4 0%
2022 4 0%
2023 4 0%
2024 5 0%

Icade Profile

About Icade

As an investor and a developer, Icade is an integrated real estate player that designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is closely involved with stakeholders and users in the cities—local authorities and communities, companies and employees, institutions and associations. As an office and healthcare property investor (portfolio value of €11.6bn as of 06/30/2020 on a proportionate consolidation basis) and as a property developer (2019 economic revenues of nearly €1bn), Icade has been able to reinvent the real estate business and foster the emergence of tomorrow's greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC). Its leading shareholder is the Caisse des dépôts Group.

CEO
Mr. Nicolas Joly
Employee
1.035
Address
Open Building
Issy-les-Moulineaux, 92130

Icade Executives & BODs

Icade Executives & BODs
# Name Age
1 Mr. Nicolas Joly
Chief Executive Officer
70
2 Ms. Emmanuelle Baboulin
Head of the Commercial Property Investment Division
70
3 Ms. Anne-Violette Faugeras
Director of Financing & Investor Relations
70
4 Mr. Jérôme Lucchini
General Secretary and Head of Governance, Legal Insurance & Department
70
5 Mr. Xavier de La Sudrie
Head of Financial Control
70
6 Ms. Sophie Duval
Head of Consolidation & Accounting
70
7 Mr. Henri Chapouthier
Head of Sustainable Development
70
8 Ms. Christelle De Robillard
Chief Financial Officer
70
9 Mr. Guillaume Tessler
Head of International Development - Icade Santé
70
10 Johannah Mrejen
Head of Asset Management
70

Icade Competitors

Gecina Logo
Gecina

GFC.PA

(2.0)
Klépierre Logo
Klépierre

LI.PA

(2.0)
Covivio Logo
Covivio

COV.PA

(2.0)
Mercialys Logo
Mercialys

MERY.PA

(2.0)
Nexity SA Logo
Nexity SA

NXI.PA

(2.0)